Merck Serono's easypod HGH injection device approved in Japan
This article was originally published in Scrip
Executive Summary
Merck Serono's electronic autoinjection device, easypod, has been approved for use with its recombinant human growth hormone, Saizen (somatropin), in Japan. The easypod device allows patients to self-inject in three steps, with the needle being hidden during the injection process. It can also deliver a preset dose and automatically record the number of doses administered, allowing physicians to check patient adherence. The device was made available in the US and a number of European countries in 2007, and is now approved in 40 countries, including the US and those in the EU.